Publication Name	World Journal of Gastroenterology
Manuscript ID	29902
Country	Australia

Received	2016-08-30 09:38
Peer-Review Started	2016-08-31 20:32
To Make the First Decision	2016-09-28 09:02
Return for Revision	2016-09-29 14:52
Revised	2016-10-05 07:44
Second Decision	2016-10-24 16:48
Accepted by Journal Editor-in-Chief	2016-10-25 16:23
Accepted by Executive Editor-in-Chief	2016-10-31 15:32
Articles in Press	2016-10-31 15:32
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-12-11 13:30
Publish the Manuscript Online	2016-12-13 00:40

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Editorial
Article Title	From blood to breath: New horizons for esophageal cancer biomarkers
Manuscript Source	Invited Manuscript
All Author List	Roger Yazbeck, Simone E Jaenisch and David I Watson
Funding Agency and Grant Number
Corresponding Author	Dr. David I Watson, Professor, Department of Surgery, Flinders Centre for Innovation in Cancer, Flinders University, Room 3D211, Bedford Park, South Australia 5042, Australia. david.watson@flinders.edu.au
Key Words	Breath analysis; Cancer; MicroRNA; Non-invasive; Esophageal cancer; Biomarker
Core Tip	The current “gold standard” test for detection of esophageal cancer is endoscopic imaging and confirmation by biopsy. There are several barriers to endoscopy as a clinical tool to monitor patients at high risk of esophageal cancer, including high capital and personnel costs and the invasive nature of the procedure. This paper highlight new insights into the development and clinical validation of circulating and breath biomarkers of esophageal cancer.
Publish Date	2016-12-13 00:40
Citation	Yazbeck R, Jaenisch SE, Watson DI. From blood to breath: New horizons for esophageal cancer biomarkers. World J Gastroenterol 2016; 22(46): 10077-10083
URL	http://www.wjgnet.com/1007-9327/full/v22/i46/10077.htm
DOI	http://dx.doi.org/10.3748/wjg.v22.i46.10077

Full Article (PDF)	WJG-22-10077.pdf
Full Article (Word)	WJG-22-10077.doc
Manuscript File	29902-Review.docx
Answering Reviewers	29902-Answering reviewers.pdf
Audio Core Tip	29902-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	29902-Conflict-of-interest statement.pdf
Copyright License Agreement	29902-Copyright assignment.pdf
Peer-review Report	29902-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	29902-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	29902-Scientific misconduct check.pdf
Scientific Editor Work List	29902-Scientific editor work list.pdf